References
Black DM, Delams PD, Eastell R, et al.: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 2007, 356:1809–1822.
Colón-Emeric C, Messenbrink P, Lyles K, et al.: Potential mediators in the reduction of mortality with zoledronic acid after hip fracture [abstract 1030]. Presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research. Montreal, Quebec, Canada; September 12–16, 2008.
Rights and permissions
About this article
Cite this article
Silverman, S.L. Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture. Curr Osteoporos Rep 7, 1–2 (2009). https://doi.org/10.1007/s11914-009-0001-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-009-0001-8